Explore the case study below, which highlights how simple RADiant makes treatment of both squamous cell carcinoma and basal cell carcinoma lesions in the dermatology clinic setting.
Xstrahl to Highlight Dual Modality Treatment Solution for Dermatologists at AOCD
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the AOCD 2024 meeting, in Scottsdale, AZ. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring. Visit Xstrahl at AOCD 2024, booth # 22 at the Westin Kierland from April 11-14, 2024.